Given that you quoted Neuren pharma if you look at the how the share price changed post approvals , it was sitting around 1 dollar mark in 2016-17 and today making highs around 22 dollars. The fact of the matter is if you have conviction with a company it is better to remain on board , risk what you are you are comfortable losing like any other business and let the company work out its way. Make sure you are there at the good time of the company to reap the profits.
banter and General Discussion, page-8186
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
0.018(1.27%) |
Mkt cap ! $1.569B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.41 | $1.38 | $975.3K | 698.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 105534 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 13169 | 7 |
View Market Depth
| Last trade - 10.40am 17/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |